Histogenics raises $65M in IPO

Histogenics Corp. (NASDAQ:HSGX) rose $0.75 to $11.75 in its first day of trading after raising $65 million in an IPO on NASDAQ through the sale of 5.9 million shares at $11. The price valued Histogenics at $140.3 million. Cowen; Needham; Canaccord Genuity and BTIG are underwriters.

Last month, Histogenics said it would sell 4.3 million shares at $13-$15. At $14, it would have raised $60 million and been valued at $151.1 million. ...